It may be that the presence of the second drug in Advair, the steroid Flovent, quells any threat posed by Serevent (the beta agonist) in many patients.
Yet a Glaxo study in 2004 found that 60% of asthma patients could control their disease with just the inhaled steroid Flovent, the other half of Advair.